Abstract
Mantle cell lymphoma (MCL), a malignancy of B-lymphocytes, has a poor prognosis. It is thus necessary to improve the understanding of the pathobiology of MCL and identify factors contributing to its aggressiveness. Our studies, based on Affymetrix data from 17 MCL biopsies, real-time quantitative polymerase chain reaction data from 18 sorted primary MCL cells and 108 MCL biopsies compared to non-malignant tissue, reveals that GNAZ expression predicts poor clinical outcome of MCL patients (Cox regression, P = 0·014) and lymphocytosis (Mann-Whitney, P = 0·011). We show that GNAZ translates to Gαz protein - a signalling molecule within the G-protein coupled receptor network. Our findings suggest that GNAZ/Gαz contribute to the MCL pathobiology.
References
Apr 21, 2001·Oncogene·M K Ho, Y H Wong
May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Birgitta SanderBirger Christensson
May 5, 2007·Cancer·Ana FerrerEmili Montserrat
Mar 21, 2012·Blood·Lina NygrenBirgitta Sander
Oct 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sílvia BeàElías Campo
Oct 3, 2014·Nature·Jagan R MuppidiJason G Cyster
Jan 17, 2015·Oncoscience·Agata M WasikBirgitta Sander
Apr 19, 2015·Haematologica·Martin LordBirgitta Sander
May 6, 2015·Experimental Hematology & Oncology·Stephen MiddleKathleen J Till
Feb 18, 2016·Nature Communications·Masao DoiHitoshi Okamura
Oct 23, 2016·Oncotarget·Chenglin WuQiang Pan-Hammarström
Oct 5, 2016·Blood·David ChironCatherine Pellat-Deceunynck
Apr 11, 2017·Journal of Internal Medicine·P GhiaF K Stevenson
Nov 1, 2017·PloS One·Patrick VancuraRainer Spessert
Aug 30, 2018·Blood·Kami Maddocks